General Biologicals Corporation (TPEX:4117)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
4.850
-2.900 (-37.42%)
Mar 10, 2026, 2:00 PM CST

General Biologicals Company Description

General Biologicals Corporation engages in the research, development, manufacture, and sales of in-vitro diagnostics in Taiwan and internationally.

It offers ELISA and chemiluminescence immunoassay, molecular and cell diagnostic, and point of care testing services.

The company also provides COVID-19, digital pathology, and contract development manufacturing organization solutions; blood screening services for hepatitis and HIV; and biomaterial, such as antibody biomaterials and human plasma.

Additionally, it offers a range of oral care products under the oh care brand. Further, the company serves its diagnostic solutions through clinics and laboratories.

General Biologicals Corporation was founded in 1984 and is headquartered in Hsinchu City, Taiwan.

General Biologicals Corporation
Country Taiwan
Founded 1984
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 81
CEO T.C. Lin

Contact Details

Address:
No. 6, Innovation First Road
Hsinchu City, 300092
Taiwan
Phone 886 3 577 9221
Website gbc.com.tw

Stock Details

Ticker Symbol 4117
Exchange Taipei Exchange
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency TWD
ISIN Number TW0004117007
SIC Code 2835

Key Executives

Name Position
Frank Lin M.B.A. President and Director
Dr. C.M. Ling Founder
Ming Shan Liu Deputy General Manager of Sales Marketing and Director